drugset / Trial / NCT01951911

Effectiveness of Ketamine in Malignant Neuropathic Pain Relief

NCT01951911

Phase 3 Withdrawn Haukeland University Hospital
RandomizedCrossoverQuadruple-blindTreatment

Summary

To see whether the addition of low-dose ketamine to a subcutaneous morphine infusion improves analgesia in patients with neuropathic cancer pain.

Timeline

Start
2013-09
Primary completion
2016-10
Completion
2016-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 1 mg/kg Subcutaneous